Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Mar;34(3):753–755. doi: 10.1128/jcm.34.3.753-755.1996

Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients.

D D'Antonio 1, A Mazzoni 1, A Iacone 1, B Violante 1, M A Capuani 1, F Schioppa 1, F Romano 1
PMCID: PMC228886  PMID: 8904454

Abstract

Blastoschizomyces capitatus strains resistant to fluconazole were isolated in three cancer patients. All of the strains had identical genomic DNA restriction profiles. Our findings give evidence for the emergence of fluconazole-resistant B. capitatus and suggest a nosocomial acquisition emanating from a common source within the hospital environment.

Full Text

The Full Text of this article is available as a PDF (217.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Girmenia C., Micozzi A., Venditti M., Meloni G., Iori A. P., Bastianello S., Martino P. Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient. Eur J Clin Microbiol Infect Dis. 1991 Sep;10(9):752–756. doi: 10.1007/BF01972503. [DOI] [PubMed] [Google Scholar]
  2. Herbrecht R., Liu K. L., Koenig H., Waller J., Dufour P., Maloisel F., Bergerat J. P., Oberling F. Septicémies à Trichosporon capitatum chez des malades immunodéprimés. Pathol Biol (Paris) 1990 Jun;38(5 ):585–588. [PubMed] [Google Scholar]
  3. Karabinis A., Hill C., Leclercq B., Tancrède C., Baume D., Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol. 1988 Mar;26(3):429–432. doi: 10.1128/jcm.26.3.429-432.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Liu K. L., Herbrecht R., Bergerat J. P., Koenig H., Waller J., Oberling F. Disseminated Trichosporon capitatum infection in a patient with acute leukemia undergoing bone marrow transplantation. Bone Marrow Transplant. 1990 Sep;6(3):219–221. [PubMed] [Google Scholar]
  5. Martino P., Venditti M., Micozzi A., Morace G., Polonelli L., Mantovani M. P., Petti M. C., Burgio V. L., Santini C., Serra P. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis. 1990 Jul-Aug;12(4):570–582. doi: 10.1093/clinids/12.4.570. [DOI] [PubMed] [Google Scholar]
  6. Matthews R. C., Burnie J. P., Fox A., Woods M., Tabaqchali S. Immunoblot analysis of the serological response in invasive Trichosporon beigelii and Blastoschizomyces capitatus infections. J Clin Microbiol. 1986 Feb;23(2):395–397. doi: 10.1128/jcm.23.2.395-397.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Millon L., Manteaux A., Reboux G., Drobacheff C., Monod M., Barale T., Michel-Briand Y. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol. 1994 Apr;32(4):1115–1118. doi: 10.1128/jcm.32.4.1115-1118.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Morace G., Manzara S., Dettori G. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole. Chemotherapy. 1991;37(1):23–31. doi: 10.1159/000238828. [DOI] [PubMed] [Google Scholar]
  9. Pincus D. H., Salkin I. F., Hurd N. J., Levy I. L., Kemna M. A. Modification of potassium nitrate assimilation test for identification of clinically important yeasts. J Clin Microbiol. 1988 Feb;26(2):366–368. doi: 10.1128/jcm.26.2.366-368.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Polacheck I., Salkin I. F., Kitzes-Cohen R., Raz R. Endocarditis caused by Blastoschizomyces capitatus and taxonomic review of the genus. J Clin Microbiol. 1992 Sep;30(9):2318–2322. doi: 10.1128/jcm.30.9.2318-2322.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ruhnke M., Eigler A., Tennagen I., Geiseler B., Engelmann E., Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol. 1994 Sep;32(9):2092–2098. doi: 10.1128/jcm.32.9.2092-2098.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Scherer S., Stevens D. A. Application of DNA typing methods to epidemiology and taxonomy of Candida species. J Clin Microbiol. 1987 Apr;25(4):675–679. doi: 10.1128/jcm.25.4.675-679.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Warnock D. W., Burke J., Cope N. J., Johnson E. M., von Fraunhofer N. A., Williams E. W. Fluconazole resistance in Candida glabrata. Lancet. 1988 Dec 3;2(8623):1310–1310. doi: 10.1016/s0140-6736(88)92919-4. [DOI] [PubMed] [Google Scholar]
  14. Willocks L., Leen C. L., Brettle R. P., Urquhart D., Russell T. B., Milne L. J. Fluconazole resistance in AIDS patients. J Antimicrob Chemother. 1991 Dec;28(6):937–939. doi: 10.1093/jac/28.6.937. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES